News

Piramal Expands API Capacity in Michigan

December 09, 2020

Piramal Pharma Solutions invests in expanded potent and non-potent API development and manufacturing at its Riverview, MI facility.

ACG Appoints New CEO

December 09, 2020

Dr. Marcus Michel will take over the role from Richard Stedman, who has served as CEO for the past three years, as he transitions to a special advisor role for the company.

Catalent to Invest $10 Million to Increase Isolator Capabilities at US and UK Sites

December 08, 2020

The company will expand its micronization abilities for highly potent drug compounds through this investment.

FDA Posts Briefing Documents for Vaccine Committee Meeting

December 08, 2020

Pfizer-BioNTech details its case for Emergency Use Authorization for "highly effective" COVID-19 vaccine.

Regenecare HA Hydrogel Recalled

December 08, 2020

The product is being recalled because of Burkholderia cepecia contamination.

Kindeva and BOL Pharma to Develop Inhaled Cannabinoid Products

December 08, 2020

A development agreement will study inhaled formulations of cannabinoid-based drug product for central nervous system diseases.

FDA Publishes Best Practices for Developing Proprietary Names for Drugs

December 08, 2020

The new guidance document is intended to minimize medication errors and avoid violations of the FD&C Act.

Combination Product Guidance Issued by FDA

December 08, 2020

The agency published guidance on how sponsors of combination products can obtain feedback from FDA on scientific and regulatory concerns.

Samsung Biologics Launches Virtual Showroom

December 08, 2020

The virtual showroom will provide real-time construction updates, various specs, and services that its new super plant, Plant 4, will offer upon completion.

Bayer and Atara Biotherapeutics Enter into Solid Tumor Treatment Agreement

December 07, 2020

The companies have entered into an agreement for next-generation, mesothelin-directed CAR-T cell therapies for the treatment of solid tumors.